Biocartis granted Johnson & Johnson's Janssen Pharmaceutica N.V. unit exclusive, worldwide rights to develop and commercialize assays on Biocartis' molecular diagnostics system

Biocartis Group N.V.

Switzerland / Medical Devices and Diagnostics

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Johnson & Johnson

U.S. / Large-Cap Biopharma (>=$50 billion)

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced